CHICAGO Ill. (October 17, 2017) - Perkins Coie represented Attune Medical, the developer of EnsoETM, the only patient temperature management system approved for use in the esophageal environment for whole-body temperature modulation, in the close of a $10 million Series C financing with participation from existing investors, several associates, and new investors.

Led by Chicago partner John Schreiner, the Perkins Coie team included Chicago associate Sarah David.

Please click here to read the Attune Medical press release.

Perkins Coie is a leading global law firm, dedicated to helping the world’s most innovative companies solve the legal and business challenges of tomorrow. Learn about our work and values here.

Media Inquiries: Please email Justin Cole, Head of Media Relations.